title: Revisiting nanoparticle technology for blood-brain barrier transport: Unfolding at the endothelial gate improves the fate of transferrin receptor-targeted liposomes.
abstract: An unmet need exists for therapeutic compounds to traverse the brain capillary endothelial cells that denote the blood-brain barrier (BBB) to deliver effective treatment to the diseased brain. The use of nanoparticle technology for targeted delivery to the brain implies that targeted liposomes encapsulating a drug of interest will undergo receptor-mediated uptake and transport through the BBB with a subsequent unfolding of the liposomal content inside the brain, hence revealing drug release to adjacent drug-demanding neurons. As transferrin receptors (TfRs) are present on brain capillary endothelial, but not on endothelial cells elsewhere in the body, the use of TfR-targeted liposomes - colloidal particulates with a phospholipid bilayer membrane - remains the most relevant strategy to obtain efficient drug delivery to the brain. However, many studies have failed to provide sufficient quantitative data to proof passage of the BBB and significant appearance of drugs inside the brain parenchyma. Here, we critically evaluate the current evidence on the use of TfR-targeted liposomes for brain drug delivery based on a thorough investigation of all available studies within this research field. We focus on issues with respect to experimental design and data analysis that may provide an explanation to conflicting reports, and we discuss possible explanations for the current lack of sufficient transcytosis across the BBB for implementation in the design of TfR-targeted liposomes. We finally provide a list of suggestions for strategies to obtain substantial uptake and transport of drug carriers at the BBB with a concomitant transport of therapeutics into the brain.
authors.affiliation: Laboratory for Neurobiology, Biomedicine, Institute of Health Science and Technology, Aalborg University, Aalborg, Denmark.
authors.forename: Kasper Bendix
authors.initials: KB
authors.lastname: Johnsen
authors.affiliation: Laboratory for Neurobiology, Biomedicine, Institute of Health Science and Technology, Aalborg University, Aalborg, Denmark. Electronic address: tmoos@hst.aau.dk.
authors.forename: Torben
authors.initials: T
authors.lastname: Moos
mesh_terms: D000818:Animals; D001692:Biological Transport; D001812:Blood-Brain Barrier / Q000378:metabolism*; D042783:Endothelial Cells / Q000378:metabolism*; D006801:Humans; D008081:Liposomes; D058990:Molecular Targeted Therapy; D053758:Nanoparticles / Q000008:administration & dosage*; D011990:Receptors, Transferrin / Q000378:metabolism*
chemical_list: D008081:Liposomes; D011990:Receptors, Transferrin
keywords: Blood–brain barrier; Capillary; Endocytosis; Nanoparticle; OX26; Transferrin; Transport